Omega-3 fatty acids and longevity: what the evidence actually says

Apparently, your red blood cells contain a measurable record of your omega-3 intake over the past three months. It’s called the omega-3 index, and a 2004 paper in Preventive Medicine by William Harris and Clemens Von Schacky argued it should be treated as a cardiovascular risk factor comparable to LDL cholesterol. That was more than twenty years ago. Most people have still never heard of it.

This is a bit of a pattern with omega-3 research. The evidence is robust, the practical implications are reasonably clear, and somehow it never quite gets the attention it deserves compared to whatever supplement is trending that month. So let’s actually look at what the science says.

What omega-3s are — and why the type matters

Omega-3 fatty acids are a family of polyunsaturated fats. Not all of them are equal for the effects we’re discussing, and this is where most of the confusion starts.

The three you’ll encounter most often:

• ALA (alpha-linolenic acid): Found in flaxseed, chia seeds, walnuts. Technically an omega-3, but not the biologically active form for most of the benefits described here.
• EPA (eicosapentaenoic acid): Found primarily in fatty fish and marine algae. Anti-inflammatory, and the form most associated with cardiovascular and mood effects.
• DHA (docosahexaenoic acid): Also from marine sources. Critical for brain structure and function — it’s a major structural component of neuronal cell membranes.

The reason ALA is largely beside the point: conversion. Your body can convert ALA into EPA, and then into DHA, but the conversion rate in healthy adults averages just 5–10% for EPA and under 1% for DHA. Eating flaxseed oil will not meaningfully raise your EPA or DHA levels. This matters enormously, because essentially all the longevity-relevant research was conducted using marine-derived EPA and DHA, not plant-derived ALA.

If you’re vegan, algae-derived omega-3 supplements are a genuinely good alternative — algae is the original source anyway, and fish simply accumulate it by eating organisms that eat algae.

The inflammation mechanism

One reason omega-3s keep appearing in longevity research is their relationship with chronic low-grade inflammation — one of the most important drivers of accelerated biological aging.

A piece of biochemistry worth knowing: EPA and DHA compete with arachidonic acid (an omega-6 fatty acid) for the same enzymes that produce inflammatory signalling molecules called eicosanoids. When EPA and DHA are abundant in cell membranes, they produce eicosanoids that are less inflammatory — or actively anti-inflammatory — compared to those derived from arachidonic acid.

This is why the ratio of omega-6 to omega-3 intake matters as much as absolute amounts. Western diets typically carry ratios of 15:1 to 20:1 omega-6 to omega-3. Traditional diets associated with low cardiovascular disease tend to sit closer to 4:1. The shift isn’t about omega-6 being inherently bad — it’s that the ratio is so far off that the buffering effect of omega-3s gets overwhelmed.

Chronic low-grade inflammation — what researchers now call inflammaging — accelerates cellular aging and sits upstream of the major diseases of aging: cardiovascular disease, neurodegeneration, type 2 diabetes, some cancers. Anything that measurably, durably reduces it is worth understanding.

The VITAL trial: the clearest evidence

For years, omega-3 research was messy — small trials, inconsistent results, too many studies funded by supplement manufacturers. Then in 2019, the New England Journal of Medicine published the VITAL trial, and things got clearer.

VITAL randomized 25,871 adults with no prior cardiovascular disease to either 1g/day of omega-3s (as n-3 fatty acid ethyl esters, EPA+DHA combined), vitamin D3, both, or placebo, and followed them for a median of 5.3 years. The omega-3 arm showed a statistically significant 28% reduction in myocardial infarction. Crucially, the benefit was most pronounced in participants who ate less than 1.5 servings of fish per week — suggesting the effect is largest where the deficiency is greatest. People already eating plenty of fatty fish showed smaller gains, which makes biological sense.

Also published in 2019 in NEJM, the REDUCE-IT trial used high-dose icosapentaenoic acid (pure EPA, 4g/day, pharmaceutical grade) in patients with elevated triglycerides and existing cardiovascular risk. The result was a 25% reduction in major adverse cardiovascular events, including a significant drop in cardiovascular death. REDUCE-IT used doses far higher than a typical fish oil capsule, and the EPA was the pharmaceutical formulation icosapent ethyl — but it established that the cardiovascular benefit scales with dose and exposure.

Taken together, these trials shifted the discussion from “does omega-3 supplementation do anything?” to “who benefits most, and at what dose?”

Telomeres: the cellular aging connection

This is the part I find genuinely interesting.

Telomeres are the protective caps at the ends of chromosomes — functionally similar to the plastic tip at the end of a shoelace. Each time a cell divides, telomeres shorten slightly. When they become critically short, the cell can no longer replicate and either becomes senescent (dormant and potentially pro-inflammatory) or dies. Telomere length has become a serious biomarker for cellular aging.

In 2010, Ramin Farzaneh-Far and colleagues published a landmark study in JAMA tracking 608 outpatients with stable coronary artery disease over five years, measuring both omega-3 blood levels and leukocyte telomere length at baseline and at follow-up.

The finding: participants in the highest quartile of baseline omega-3 levels showed significantly slower telomere shortening over those five years compared to those in the lowest quartile. The association held after adjusting for age, sex, and other cardiovascular variables. Higher omega-3 exposure correlated with meaningfully less cellular aging over a five-year period.

The mechanism isn’t fully established, but the strongest hypothesis involves oxidative stress and inflammation. Both accelerate telomere shortening; both are modulated by EPA and DHA. There’s also preliminary evidence that omega-3s may influence telomerase activity — the enzyme that repairs and extends telomeres — though this is less conclusively demonstrated.

A 2021 meta-analysis in Nutrients synthesizing 16 observational studies found that higher omega-3 intake was consistently associated with longer telomere length across diverse populations. Bit nerdy, but as a mechanistic story connecting a dietary factor to a fundamental cellular aging process, it’s quite compelling.

Brain aging and cognitive health

DHA is the dominant fatty acid in neuronal cell membranes. The brain is roughly 60% fat by dry weight, and DHA accounts for a substantial proportion of that — particularly in the grey matter regions most associated with higher cognition. It’s not passive structural material; DHA affects membrane fluidity, synaptic function, and neuroinflammation.

Epidemiological studies have consistently found associations between higher omega-3 intake and lower rates of cognitive decline. The MIDAS trial, published in 2010 in Alzheimer’s & Dementia, found that 900mg/day of DHA improved episodic memory and learning in healthy older adults with age-related mild memory complaints. The effect wasn’t dramatic, but it was consistent and dose-responsive.

More recent analyses from the Framingham Heart Study found that lower omega-3 index values were associated with smaller brain volumes and worse scores on cognitive tests, even in middle-aged adults without any diagnosed cognitive impairment. The argument the research is building toward is a prevention case: maintaining DHA sufficiency over decades preserves neuronal membrane integrity and reduces neuroinflammation, before cognitive symptoms ever appear.

To be clear: omega-3s are not a treatment for Alzheimer’s, and no supplement has convincingly reversed established dementia. The case being made is for sufficiency and prevention — not deficiency going uncorrected for years — rather than for any therapeutic effect.

The omega-3 index: a practical biomarker

The omega-3 index is worth understanding because it converts the abstract “eat more fish” message into something measurable and trackable.

The test measures EPA+DHA as a percentage of total fatty acids in red blood cell membranes. Because red blood cells turn over approximately every three months, the index reflects your average intake over that period — not what you ate yesterday. It’s far more reliable than dietary recall.

Target ranges based on the published research:

• Above 8%: Low cardiovascular risk zone
• 4–8%: Intermediate risk
• Below 4%: High risk — where most adults on Western diets sit

The original 2004 Harris and Von Schacky paper proposed the omega-3 index specifically as a modifiable risk factor. A 2021 analysis in Progress in Cardiovascular Diseases found it independently predicted sudden cardiac death risk beyond what standard lipid panels capture.

Getting from 4% to 8% typically takes 3–4 months of consistent intake changes: either eating fatty fish 2–3 times per week or supplementing with 1–2g EPA+DHA daily. The body responds quite reliably once you’re consistent.

Food sources versus supplements

Food first — this is worth stating clearly, not as a formality. Three servings of fatty fish per week will move most people into the optimal range while also delivering protein, selenium, vitamin D, and iodine that capsules don’t include.

Approximate EPA+DHA content per 100g of cooked fish:

• Mackerel: ~2.5g
• Wild salmon: ~1.8–2.5g
• Herring: ~1.8g
• Sardines: ~1.5g
• Anchovies: ~1.5g
• Canned tuna: ~0.5–1.2g (varies significantly by type and brand)

For supplements, quality varies more than the label usually acknowledges. Fish oil oxidizes, which affects both efficacy and the “fishy repeat” situation. Triglyceride-form omega-3s are better absorbed than ethyl ester forms, which are the cheaper synthetic version used in many mass-market products. Keep capsules in the fridge, check the expiry date, and if the capsule smells rancid when you cut it open, it is rancid. That batch isn’t doing much useful work.

Common misconceptions worth clearing up

“I eat chia seeds so I’m sorted.” See above on ALA conversion. Plant-based omega-3s don’t meaningfully raise EPA or DHA levels. If you’re not eating fish or taking algae-derived supplements, your omega-3 index is almost certainly low regardless of how many seeds are in your smoothie.

“I take fish oil so I’m covered.” Maybe. A typical 1g fish oil capsule often contains only 300–500mg of actual EPA+DHA — the rest is other fats. Read the label: look for the EPA+DHA numbers specifically, not just “omega-3.”

“More is always better.” Not at very high doses. Above 5g/day there are legitimate concerns around bleeding time and immune modulation. The research-supported range is 1–4g of combined EPA+DHA daily. VITAL’s cardiovascular benefits appeared at 1g/day in a population with low fish intake.

“It’s just a heart thing.” The telomere and brain aging data suggest omega-3 sufficiency is relevant to cellular aging and cognitive health in ways that go well beyond cardiovascular risk. It sits at a convergence of multiple aging mechanisms.

What this looks like in practice

If you’re eating salmon, mackerel, or sardines twice a week, you’re probably doing reasonably well. A direct-to-consumer omega-3 index test — available from several labs — will tell you your actual number rather than making you guess.

If you don’t eat fish regularly, a 1–2g EPA+DHA supplement daily is a well-evidenced, practical choice. Not a silver bullet, not a replacement for the broader picture — but among the highest-evidence nutritional interventions for long-term health by almost any metric.

Context matters though. Omega-3s work best as part of a broader anti-inflammatory dietary pattern — they’re competing with omega-6 intake from processed foods and seed oils, so the ratio matters as much as the absolute dose. Adding fish oil on top of a diet dominated by ultra-processed food is better than nothing, but the gap between that and simply eating more fatty fish alongside better overall food quality is significant.

The broader nutritional picture for longevity is worth reading if you haven’t — omega-3 sufficiency is one well-evidenced piece of it rather than the whole story.

Anyway. Worth knowing your number if you’ve never checked.